Panic Disorder — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for panic disorder. 4 active patents protecting 1 drugs from 1+ originators. First major cliff: 2034. Daily refresh.

1
Approved drugs
4
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered

Originators in Panic Disorder

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Wyeth/Pfizer) 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating panic disorder. Each bar = one year. Y-axis scaled to peak year (4 patents).

4
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Ativan
lorazepam
 Generic (originally Wyeth/Pfizer) 4 64 — 2034-01-08

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8999393 Ativan method of use 70 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 70 2034-01-08

Related